Amid heightened global uncertainty at the start of the crisis, clinical trial management group ICON established a business continuity team to ensure the company was prepared for any eventuality. The company, which is listed on the Nasdaq exchange in New York, describes its management style as open and data-driven, and it was that style that drove the company’s response to the Covid-19 crisis. With 15,000 employees in 90 offices across 40 countries, ICON is a global leader at providing outsourced development services on a global basis to the pharmaceutical, biotechnology, and medical device industries. It operates through a partnership model…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €100.

Subscribe

Cancel anytime.

Are you already a member? .